Oridonin induces apoptosis in oral squamous cell carcinoma probably through the generation of reactive oxygen species and the p38/JNK MAPK pathway
Document Type: Research Article
Affiliations: 1: Department of Pharmacy, College of Pharmacy and Natural Medicine Research Institute, Mokpo National University, Jeonnam 58554, Republic of Korea 2: Department of Dental Pharmacology, School of Dentistry and Institute of Oral Bioscience, BK21 Plus, Chonbuk National University, Jeonju 54896, Republic of Korea 3: The China-US (Henan) Hormel Cancer Institute, Zhengzhou, Henan 450008, P.R. China 4: Department of Biological Sciences, Dong-A University, Busan 49315, Republic of Korea 5: Animal Biotechnology Division, National Institute of Animal Science, RDA, Wanju 55365, Republic of Korea 6: Department of Pharmacy, Keimyung University, Daegu 42601, Republic of Korea 7: College of Pharmacy and Research Institute of Life and Pharmaceutical Sciences, Sunchon National University, Sunchon 57922, Republic of Korea 8: Department of Family Medicine, Medical Hospital, Wonkwang University, Iksan, Chonbuk 54538, Republic of Korea
Publication date: 01 May 2018
- The International Journal of Oncology provides an international forum for the publication of the latest, cutting-edge research in the broad area of oncology and cancer treatment. The journal accepts original high quality works and reviews on all aspects of oncology research including carcinogenesis, metastasis, epidemiology, chemotherapy and viral oncology. Through fair and efficient peer review, the journal is dedicated to publishing top tier research in the field, offering authors rapid publication as well as high standards of copy-editing and production. The International Journal of Oncology is published on a monthly basis in both print and early online.
- Editorial Board
- Information for Authors
- Submit a Paper
- Subscribe to this Title
- Information for Advertisers
- Terms & Conditions
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content